Transforming Sanofi-Aventis

            
 
Case Studies | Cases in Business, Management, Cases | Case Study

ICMR HOME | Case Studies Collection

Case Details:

Case Code : BSTR358
Case Length : 18 Pages
Period : 2008-2009
Pub Date : 2010
Teaching Note :Not Available
Organization : Sanofi-Aventis
Industry : Healthcare / Pharmaceuticals
Countries : France; Global

To download Transforming Sanofi-Aventis case study (Case Code: BSTR358) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies



Price:

For delivery in electronic format: Rs. 300;
For delivery through courier (within India): Rs. 300 + Shipping & Handling Charges extra

Business Strategy Case Studies
Case Studies Collection
Business Strategy Short Case Studies
View Detailed Pricing Info
How To Order This Case
Business Case Studies
Area Specific Case Studies
Industry Wise Case Studies
Company Wise Case Studies

Custom Search


Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

<< Previous

Excerpts Contd...

Diversification

According to Viehbacher, in order to serve the world's population, Sanofi-Aventis had to move away from the blockbuster model and strengthen its presence in other healthcare segments such as vaccines, consumer health, generics, and biologics...

Disciplined Acquisitions

Experts felt that patent expiries, unproductive R&D pipelines, fewer drugs approved each year and lower sales from new drugs, were forcing old-line pharmaceutical companies to opt for mega-mergers or bolt-on acquisitions. Mega-mergers were multi-billion dollar deals between two major pharmaceutical companies aimed at creating a company with more drugs and opportunities to cut costs...

Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

Looking Ahead

For the first half of 2009, the company showed good performance. In particular, Sanofi-Aventis's Q2 revenue and net profit increased significantly over the previous year, and the company raised its 2009 earnings-per-share guidance by three percentage points to 10%...

Exhibits

Exhibit I: Consolidated Income Statement: First Half 2009 (€ million)
Exhibit II: Sanofi-Aventis Five-Year Stock Chart
Exhibit III: Sanofi-Aventis' Position in Various Segments: 2008
Exhibit IV: Top Ten Pharmaceutical Companies by Global Sales
Exhibit V: Sanofi-Aventis' Income Statement
Exhibit VI: Sanofi-Aventis' Balance sheet
Exhibit VII: Sanofi-Aventis' Financial Ratios
Exhibit VIII: Sanofi-Aventis' Top Products: 2008
Exhibit IX: Sanofi-Aventis' R&D Portfolio
Exhibit X: New Drug Development Timeline for the US
Exhibit XI: Global Pharmaceutical Sales by Region: 2008
Exhibit XII: Top Ten Pharmaceutical Companies after Mergers

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies


Custom Search





Case Studies in Business Strategy Volume VI

Case Studies in Business Strategy
e-Book on Business Strategy

Case Study Volumes Collection

Business Strategy
Workbooks Collection

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.